Vestaron Corporation, a developer of peptide-based crop protection products, announced a research and development collaboration with Bioinsectis S.L., an innovator in developing novel biopesticides.
In this partnership Vestaron and Bioinsectis will work exclusively utilizing Bioinsectis’ next generation Cry-protein based technologies to develop enhanced bioavailability for insecticidal peptides. Utilizing Bioinsectis’ Cry-protein bioavailability capabilities, Vestaron expects to offer additional unique and flexible insecticide formulations to help meet growers’ crop protection needs.
“We are excited to partner with Bioinsectis on this innovative new technology to allow Vestaron to continue to bring new sustainable crop protection solutions,” said Anna Rath, CEO of Vestaron. “This collaboration is a testament to our commitment to continually evolve our insecticidal crop protection solutions to bring more effective products to market and to address the growing insect resistance concerns of farmers.”
Bioinsectis uses the power of nature to design, develop and produce insecticidal solutions derived from microbes. Cry-proteins are insecticidal proteins isolated from Bacillus thuringiensis strains that can offer unique bioavailability solutions for Vestaron’s products.
“The exclusive agreement between Bioinsectis and Vestaron represents an important step in advancing the biological transition the crop protection sector is experiencing,” said Primitivo Caballero, CEO of Bioinsectis. “We are eager to collaborate with a company that is leading the field through a commitment to innovation.”